排序方式: 共有53条查询结果,搜索用时 0 毫秒
1.
Chaker Ben Salem Wafa Saidi Sofiene Larif Neila Fathallah Raoudha Slim Houssem Hmouda 《Indian journal of pharmacology》2015,47(1):123-124
Allopurinol hypersensitivity syndrome (AHS) is a severe drug reaction. It is characterized by rash, fever, and internal organ involvement. It may present in different clinical forms. We present a case of acute generalized exanthematous pustulosis occurring as a manifestation of AHS.KEY WORDS: Allopurinol, hypersensitivity syndrome, pustulosis 相似文献
2.
3.
Hmouda H Ben Salem C Bouraoui K Jemni L 《Archives of internal medicine》2007,167(11):1207-8; author reply 1208-9
4.
5.
Hmouda H Ben Salem C Bouraoui K Jemni L 《The Journal of antimicrobial chemotherapy》2006,58(6):1307; author reply 1307-1307; author reply 1308
6.
7.
Hmouda H Ben Salem C Bouraoui K 《Lancet》2008,371(9631):2170; author reply 2170-2170; author reply 2171
8.
9.
A. Hamaï H. Benlalam F. Meslin M. Hasmim T. Carré I. Akalay B. Janji G. Berchem M. Z. Noman & S. Chouaib 《Tissue antigens》2010,75(1):1-8
Abstract
Accumulating evidence indicates that the innate and adaptive immune systems participate in the recognition and destruction of cancer cells by a process known as cancer immunosurveillance. Tumor antigen-specific cytotoxic T-lymphocytes (CTL) are the major effectors in the immune response against tumor cells. The identification of tumor-associated antigen (TAA) recognized primarily by CD 8+ T-lymphocytes has led to the development of several vaccination strategies that induce or potentiate specific immune responses. However, large established tumors, which are associated with the acquisition of tumor resistance to specific lysis, are usually not fully controlled by the immune system. Recently, it has become clear that the immune system not only protects the host against tumor development but also sculpts the immunogenic phenotype of a developing tumor and can favor the emergence of resistant tumor cell variants. Moreover, it has become obvious that the evasion of immunosurveillance by tumor cells is under the control of the tumor microenvironment complexity and plasticity. In this review, we will focus on some new mechanisms associated with the acquisition of tumor resistance to specific lysis during tumor progression, involving genetic instability, structural changes in cytoskeleton, and hypoxic stress. We will also discuss the interaction between CTLs and tumor endothelial cells, a major component of tumor stroma. 相似文献
Accumulating evidence indicates that the innate and adaptive immune systems participate in the recognition and destruction of cancer cells by a process known as cancer immunosurveillance. Tumor antigen-specific cytotoxic T-lymphocytes (CTL) are the major effectors in the immune response against tumor cells. The identification of tumor-associated antigen (TAA) recognized primarily by CD 8
10.